Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Health Yuan was included in S&P Global's Sustainability Yearbook 2025 (Global Edition) for its innovation-driven sustainable development.
Published Time：
2025-02-14
Recently, HealthGen Biotech Group was successfully included in S&P Global's Sustainability Yearbook 2025 (Global Edition) due to its outstanding performance in Environmental, Social, and Governance (ESG). This honor not only demonstrates HealthGen's continuous efforts and remarkable achievements in sustainable development but also signifies the company's leading position in ESG practices within the global pharmaceutical industry.
Global Authority Recognition: HealthGen's ESG Practices Receive International Affirmation
S&P Global's Sustainability Yearbook is one of the world's most influential ESG assessments, awarding only companies with exceptional performance in sustainable development. This year, HealthGen's outstanding achievements in green environmental protection, social responsibility, and corporate governance secured its place on this list. This reflects the high recognition of the company's sustainable development strategy by international authoritative institutions and further enhances HealthGen's influence in the global capital market.
Accelerated Innovative Drug R&D Promotes High-Quality Development of the Pharmaceutical Industry
As an innovation-driven pharmaceutical company, HealthGen continues to increase investment in innovative drugs and actively promotes high-end drug research and development. Currently, the company has more than 20 innovative drug products under development, with 7 having entered clinical Phase II or later. These innovative drugs cover areas such as respiratory, analgesic, digestive, cardiovascular, and mental diseases, demonstrating HealthGen's profound strength in cutting-edge pharmaceutical technology. Through continuous innovation, HealthGen not only contributes to the high-quality development of the domestic pharmaceutical industry but also further enhances the competitiveness of Chinese pharmaceutical companies in the global market.
AI Empowers Pharmaceutical R&D and Enables Enterprise Intelligent Upgrading
In the wave of digital transformation and intelligent manufacturing, HealthGen actively embraces cutting-edge technologies and promotes the deep application of artificial intelligence (AI) in pharmaceutical research and development, production, and management. The company has integrated advanced AI models such as DeepSeek, applying them to various stages including drug research and development, data analysis, and experimental optimization. The introduction of AI technology not only accelerates the new drug development process and improves the success rate but also significantly enhances operational efficiency, laying a solid foundation for HealthGen to build a smart, data-driven future.
Practicing ESG Principles to Create a Green and Sustainable Development Model
HealthGen always regards sustainable development as one of its core development strategies, committed to building a green, low-carbon, and efficient modern pharmaceutical enterprise. In the production process, the company continuously optimizes its processes, reduces carbon emissions, promotes the use of renewable energy, and strengthens sustainable supply chain management. In addition, HealthGen actively participates in social welfare undertakings, pays attention to public health issues, and promotes the common progress of the industry.
In terms of corporate governance, HealthGen continuously improves its compliance management system and optimizes information disclosure transparency to ensure the company's stable operation while promoting long-term sustainable growth.
Leading the Future of the Industry: Continuously Deepening the Sustainable Development Strategy
Being included in the S&P Global Sustainability Yearbook 2025 (Global Edition) is not only an affirmation of HealthGen's existing ESG achievements but also an encouragement for the company to continue deepening its sustainable development strategy in the future. In the future, HealthGen will continue to take innovative research and development, intelligent upgrading, and green sustainable development as its core strategic directions, promoting high-quality development, contributing to global health, and making greater contributions to human health.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.